Aprogen KIC Inc. (KOSE:A007460) agreed to acquire additional 5.6% stake in Aprogen pharmaceuticals,Inc. (KOSE:A003060) for KRW 17.8 billion on January 14, 2020. Post acquisition, Aprogen KIC Inc. will hold 45.93% stake in Aprogen pharmaceuticals,Inc.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,062 KRW | +5.15% | +5.04% | -63.38% |
1st Jan change | Capi. | |
---|---|---|
-63.38% | 47.97M | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- A003060 Stock
- News Aprogen Biologics Inc.
- Aprogen KIC Inc. agreed to acquire additional 5.6% stake in Aprogen pharmaceuticals,Inc. for KRW 17.8 billion.